Raymon Klein MD
Article
Apixaban plus a P2Y12 inhibitor best balances bleeding and ischemic events in patients with atrial fibrillation and recent acute coronary syndrome or percutaneous coronary intervention
May 2, 2022
Clinical question: Can the HAS-BLED and CHA2DS2-VASc scores be used to identify subgroups of patients with atrial fibrillation (AF) and recent acute coronary syndrome (ACS) or percutaneous coronary...